soul trial oral semaglutide cardiovascular outcomes 2025 results align more closely with attained dose than achieved weight loss Oral Semaglutide Yields Excellent CV

NICE technology appraisals TA875 (semaglutide 2.4mg/Wegovy) and TA664 (liraglutide 3mg/Saxenda) support their use specifically for weight management in adults within specialist weight management services

Anti-inflammatory Effects: Beyond appetite regulation, emerging research suggests that GLP-1 therapies may also contribute to lowering CRP (C-reactive protein), a key inflammatory marker

Low-dose draws are sensitive to the chosen dilution

Mitochondria regulation in ferroptosis

When people desperately want something they cannot easily get, they become more susceptible to products that promise a convenient alternative